Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha Purington

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2018
Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination CoverageJonathan Altamirano, Natasha Purington, Rasika Behl, et al.
Eclinicalmedicine|June 14, 2019
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued <i>vs</i> Discontinued Dosing in Multifood Allergic IndividualsSandra Andorf, Natasha Purington, Divya Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 21, 2022
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialMarisa Holubar, Aruna Subramanian, Natasha Purington, et al.
Nature Communications|March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trialPrasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 26, 2021
Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-AnalysisPaul J Turner, Nandinee Patel, Barbara K Ballmer-Weber, et al.
JCI Insight|July 8, 2022
Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndromeXiaolin Jia, Shu Cao, Alexandra S Lee, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2018
Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination CoverageJonathan Altamirano, Natasha Purington, Rasika Behl, et al.
Eclinicalmedicine|June 14, 2019
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued <i>vs</i> Discontinued Dosing in Multifood Allergic IndividualsSandra Andorf, Natasha Purington, Divya Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 21, 2022
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialMarisa Holubar, Aruna Subramanian, Natasha Purington, et al.
Nature Communications|March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trialPrasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 26, 2021
Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-AnalysisPaul J Turner, Nandinee Patel, Barbara K Ballmer-Weber, et al.
JCI Insight|July 8, 2022
Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndromeXiaolin Jia, Shu Cao, Alexandra S Lee, et al.
Pageof 5